Bio-Techne (NASDAQ:TECH) Rating Lowered to Neutral at Robert W. Baird
Bio-Techne (NASDAQ:TECH – Get Free Report) was downgraded by stock analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, MarketBeat Ratings reports. They currently have a $68.00 price target on the biotechnology company’s stock, down from their prior price target of $88.00. Robert W. Baird’s […]
Bio-Techne (NASDAQ:TECH – Get Free Report) was downgraded by stock analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, MarketBeat Ratings reports. They currently have a $68.00 price target on the biotechnology company’s stock, down from their prior price target of $88.00. Robert W. Baird’s […]
